2585 related articles for article (PubMed ID: 19123073)
1. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
2. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
3. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
4. Productive cough is an independent risk factor for the development of COPD in former smokers.
Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
[TBL] [Abstract][Full Text] [Related]
5. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
7. The effect of body mass index on functional parameters and quality of life in COPD patients.
Salepçi B; Eren A; Cağlayan B; Fidan A; Torun E; Kiral N
Tuberk Toraks; 2007; 55(4):342-9. PubMed ID: 18224501
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
[TBL] [Abstract][Full Text] [Related]
9. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
10. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
[TBL] [Abstract][Full Text] [Related]
11. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
16. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
17. [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease].
Soyyiğit S; Erk M; Güler N; Kilinç G
Tuberk Toraks; 2006; 54(3):259-66. PubMed ID: 17001544
[TBL] [Abstract][Full Text] [Related]
18. [The effect of controlled and uncontrolled dynamic lower extremity training in the rehabilitation of patients with chronic obstructive pulmonary disease].
Varga J; Boda K; Somfay A
Orv Hetil; 2005 Oct; 146(44):2249-55. PubMed ID: 16302356
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of montelukast in stable patients with moderate to severe COPD.
Celik P; Sakar A; Havlucu Y; Yuksel H; Turkdogan P; Yorgancioglu A
Respir Med; 2005 Apr; 99(4):444-50. PubMed ID: 15763450
[TBL] [Abstract][Full Text] [Related]
20. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
